or Try an Advanced Search...

    Bone Disease Stocks List

    Symbol Grade Name % Change
    AMGN B Amgen Inc. 1.16
    KROS D Keros Therapeutics, Inc. 3.61
    SMLR F Semler Scientific, Inc. 4.99
    PROF F Profound Medical Corp. 1.47
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Medical Appliances & Equipment
    Related Stock Lists: Bone Medicine Hematology Organ Systems Prostate Cancer Therapeutic Products Ablation Anemia Biopharmaceutical Biotechnology Blood Cells Cancer Care Cardiovascular Disease Chronic Disease Clinic Clinical Medicine Diabetes Dialysis Disability Disease

    Related ETFs - A few ETFs which own one or more of the above listed Bone Disease stocks.

    Symbol Grade Name Weight
    BBH C Market Vectors Biotech ETF 15.02
    IBBQ C Invesco Nasdaq Biotechnology ETF 8.78
    IBB D iShares Nasdaq Biotechnology Index Fund 8.78
    BIS D ProShares UltraShort Nasdaq Biotechnology 8.14
    BIB C ProShares Ultra Nasdaq Biotechnology 6.25
    View all Bone Disease ETFs...
    Compare ETFs
    Compare BBH to IBB Compare IBB to BIS Compare IBBQ to BIB

        Bone Disease Stocks Recent News

        Date Stock Title
        May 9 AMGN CytomX slides after early data for Amgen-partnered cancer drug
        May 9 AMGN Q1 2024 CytomX Therapeutics Inc Earnings Call
        May 8 SMLR Semler Scientific: Great Product Can Still Thrive Post Medicare Advantage
        May 8 SMLR Semler Scientific, Inc. (NASDAQ:SMLR) Q1 2024 Earnings Call Transcript
        May 7 SMLR Semler Scientific, Inc. (SMLR) Q1 2024 Earnings Call Transcript
        May 7 SMLR Semler Scientific Inc (SMLR) Q1 Earnings: Mixed Results Amid Revenue Decline and Net Income Growth
        May 7 SMLR Semler Scientific GAAP EPS of $0.78 misses by $0.25, revenue of $15.9M misses by $5.5M
        May 7 SMLR Semler Scientific® Reports First Quarter 2024 Financial Results
        May 7 AMGN 15 Best S&P 500 Dividend Stocks To Buy Now
        May 6 SMLR Semler Scientific Q1 2024 Earnings Preview
        May 6 PROF Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
        May 6 AMGN Investors Pile Into Amgen in Search of Next Obesity Drug Payout
        May 5 AMGN Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update
        May 4 AMGN Amgen First Quarter 2024 Earnings: EPS Misses Expectations
        May 4 AMGN Amgen Could Become A Real Contender In The Obesity Market
        May 4 AMGN Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
        May 3 AMGN Why Amgen Stock Zoomed Nearly 12% Higher Today
        May 3 AMGN Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
        May 3 AMGN Analyst unveils Amgen stock price target after weight-loss drug data
        May 3 KROS Keros Therapeutics files automatic mixed shelf
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Medical Appliances & Equipment
        Related Stock Lists: Bone Medicine Hematology Organ Systems Prostate Cancer Therapeutic Products Ablation Anemia Biopharmaceutical Biotechnology Blood Cells Cancer Care Cardiovascular Disease Chronic Disease Clinic Clinical Medicine Diabetes Dialysis Disability Disease
        Bone Disease

        Bone disease refers to the medical conditions which affect the bone.

        More about Bone Disease
        Browse All Tags